EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Interaction Between PNPLA3 and SIRT5 Genetic Variants in Association with Liver Fibrosis Severity in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease

Kamonchanok Moonlisarn, Pornjira Somnark, Bootsakorn Boonkaew, Chalermarat Bunchorntavakul iD, Pisit Tangkijvanich iD

Genes · 24.10.2024 · 15 (11) · 1370

DOI: 10.3390/genes15111370 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes, online erschienen am 24.10.2024. Verfasst von Kamonchanok Moonlisarn und 4 weiteren Autor:innen. Beteiligte Einrichtung: Center of Excellence in Hepatitis and Liver Cancer, Department of Biochemistry, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailan…. Hauptthemen laut MEDLINE: Lipase, Membrane Proteins, Liver Cirrhosis, Polymorphism, Single Nucleotide. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NSRF via the Program Management Unit for Human Resources & Institutional Development, Research and Innovation (PMU-B), NSRF via the Program Management Unit for Human Resources & Institutional Development, Research and Innovation, Center of Excellence in Hepatitis and Liver Cancer, Chulalongkorn University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: This study evaluated the association between polymorphisms in the PNPLA3, TM6SF2, HSD17B13, and SIRT5 genes and the severity of fibrosis and steatosis in metabolic dysfunction-associated steatotic liver disease (MASLD).

Methods

Fibrosis and steatosis were assessed by MRE and MRI-PDFF, respectively. The polymorphisms were determined by allelic discrimination in blood samples.

Results

204 patients aged 57.0 ± 13.5 years were included. Sixty-two (30.4%) patients had significant fibrosis (≥F2). Among F2–F4 fibrosis, the PNPLA3 rs738409 GG genotype was significantly higher than the CC + CG genotypes (44.9% vs. 21.4%, p = 0.001). The SIRT5 rs12216101 GG vs. TT + TG genotypes also exhibited a similar trend (64.3% vs. 27.9%, p = 0.012). In multivariate analysis, the PNPLA3 GG genotype (OR = 3.48, 95%CI: 1.50–8.06; p = 0.004) and SIRT5 rs12216101 GG genotype (OR = 5.43, 95%CI: 1.32–22.33; p = 0.019) were independently associated with F2–F4 fibrosis. Additionally, the proportion of patients with F2–F4 fibrosis significantly increased with the number of combined risk genotypes. Among S2–S3 steatosis, the prevalence of HSD17B13 AG + GG genotypes was higher than that of the AA genotype (37.5% vs. 23.9%, p = 0.048) and independently associated with moderate/severe steatosis in multivariate analysis (OR = 2.26, 95%CI: 1.14–4.49; p = 0.020).

Conclusions

Our data indicate that the PNPLA3 and SIRT5 polymorphisms were independently and additively linked to significant fibrosis, while the HSD17B13 polymorphism was associated with increased steatosis in Thai populations. These data might emphasize the importance of genetic variants in progressive MASLD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LipaseMembrane ProteinsLiver CirrhosisPolymorphism, Single NucleotideSirtuinsHumansFemaleMiddle AgedMaleAgedFatty LiverAdult17-Hydroxysteroid DehydrogenasesGenetic Predisposition to DiseaseSeverity of Illness IndexGenotypeAcyltransferasesPhospholipases A2, Calcium-Independent

Stichwörter der Autor:innen

HSD17B13 rs6834314PNPLA3 rs738409SIRT5 rs12216101fibrosismetabolic dysfunction-associated steatotic liver disease (MASLD)polymorphismssteatosis

Substanzen

PNPLA3 protein, humanLipaseMembrane ProteinsSirtuinsSIRT5 protein, humanHSD17B13 protein, human17-Hydroxysteroid DehydrogenasesTM6SF2 protein, humanAcyltransferasesPhospholipases A2, Calcium-Independent

Autor:innen und Institutionen

  • Center of Excellence in Hepatitis and Liver Cancer, Department of Biochemistry, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand.
  • Division of Gastroenterology, Department of Medicine, Rajavithi Hospital, Bangkok 10400, Thailand.

ORCID-Profile: Chalermarat Bunchorntavakul, Pisit Tangkijvanich

Förderung

  • NSRF via the Program Management Unit for Human Resources & Institutional Development, Research and Innovation (PMU-B)
  • NSRF via the Program Management Unit for Human Resources & Institutional Development, Research and Innovation
  • Center of Excellence in Hepatitis and Liver Cancer, Chulalongkorn University

Zitieren

APA

Moonlisarn, K., Somnark, P., Boonkaew, B., Bunchorntavakul, C., & Tangkijvanich, P. (2024). Interaction Between PNPLA3 and SIRT5 Genetic Variants in Association with Liver Fibrosis Severity in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease. Genes, 15(11), 1370. https://doi.org/10.3390/genes15111370

Vancouver

Moonlisarn K, Somnark P, Boonkaew B, Bunchorntavakul C, Tangkijvanich P. Interaction Between PNPLA3 and SIRT5 Genetic Variants in Association with Liver Fibrosis Severity in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease. Genes. 2024;15(11):1370. doi:10.3390/genes15111370

BibTeX
@article{Moonlisarn2024,
  author = {Moonlisarn, Kamonchanok and Somnark, Pornjira and Boonkaew, Bootsakorn and Bunchorntavakul, Chalermarat and Tangkijvanich, Pisit},
  title = {Interaction Between PNPLA3 and SIRT5 Genetic Variants in Association with Liver Fibrosis Severity in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease},
  journal = {Genes},
  year = {2024},
  volume = {15},
  number = {11},
  pages = {1370},
  doi = {10.3390/genes15111370}
}
Kostenlos starten →